Clinicopathological features and prognosis of kidney injury in patients after hematopoietic stem cell transplantation.
10.3760/cma.j.cn112150-20220618-00623
- Author:
Hong HUANG
1
;
Rong XU
2
Author Information
1. Department of Nephrology, Beijing Shunyi District Hospital, Beijing 101300,China.
2. Department of Nephrology, Peking University First Hospital, Beijing 100034,China.
- Publication Type:Journal Article
- MeSH:
Humans;
Retrospective Studies;
Kidney/pathology*;
Hematopoietic Stem Cell Transplantation/methods*;
Thrombotic Microangiopathies/pathology*;
Renal Insufficiency, Chronic/pathology*
- From:
Chinese Journal of Preventive Medicine
2023;57(6):918-922
- CountryChina
- Language:Chinese
-
Abstract:
To summarize the clinicopathological features and prognosis of kidney injury after hematopoietic stem cell transplantation (HSCT), to provide basis for preventing its occurrence and development. By using a retrospective cohort study method, we collected the clinical and renal biopsy pathological data of all the patients who hospitalized in the Department of Nephrology of Peking University First Hospital from June 2011 to June 2021 with renal injury after HSCT and underwent renal biopsy, and prognosis was followed up by telephone. The clinical laboratory characteristics, renal pathology and prognosis, and their association were analyzed. The results showed that the most common clinical phenotype was chronic kidney disease (CKD,69.2%, 18/26), in this term 13/18 patients received stem cells from haploidentical donors, and 11/18 patients experienced with extrarenal graft-versus-host disease (GVHD). The most common pathologic phenotype was thrombotic microangiopathy (TMA, 61.5%, 16/26). Renal function returned to baseline level in 6 patients, and the kidney survival at 2 years and 5 years were 95.7% (22/23) and 87.5% (14/16), respectively. In conclusion, the clinical phenotype of renal injury after HSCT were mainly CKD, and the most common pathologic phenotype was TMA, the long-term prognosis was favourable.
